Liver enzymes such as γ-glutamyltransferase (GGT), alanine aminotransferase (ALT), and aspartate aminotransferase (AST), have been used as markers of hepatic dysfunction and non-alcoholic fatty liver disease (NAFLD)1. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.